CompanyGraph
Cambridge Nutritional Sciences Ltd.
CNSL · United Kingdom
cnsplc.comFinancials as of FY2025 · latest on file
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $5.62M, lower than 95% of all stocks globally
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2025 (year ended March 31, 2025). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
4.16MGBP5.62M · vs all stocks (USD)
Trailing P/E
1.75xvs Medical Instruments & Supplies peers
Revenue (TTM)
8.06MGBP10.88M · vs all stocks (USD)
Profit Margin
16.94%vs Medical Instruments & Supplies peers
Beta
1.91xvs all stocks
52-Week Change
-53.33%vs all stocks
Market Capitalization
4.16MGBP5.62M · vs all stocks (USD)
Enterprise Value
807.14KGBP1.09M · vs all stocks (USD)
Trailing P/E
1.75xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.5167xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.3804xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.1000xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-2.48xvs Medical Instruments & Supplies peers
Profit Margin
16.94%vs Medical Instruments & Supplies peers
Operating Margin
-7.69%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-2.58%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
13.26%vs Medical Instruments & Supplies peers
Revenue (TTM)
8.06MGBP10.88M · vs all stocks (USD)
Revenue per Share (TTM)
0.0340GBPUpdated Jul 28, 2026Quarterly Revenue Growth
-6.60%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
5.35MGBP7.23M · vs all stocks (USD)
EBITDA (TTM)
367.00KGBP495.64K · vs all stocks (USD)
Net Income (TTM)
1.36MGBP1.84M · vs all stocks (USD)
Operating Cash Flow (TTM)
-270.00KGBP-364.64K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-49.88KGBP-67.36K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Jul 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
8.33MGBPFY2025 · Mar 31, 2025Cost of Goods Sold
2.89MGBPFY2025 · Mar 31, 2025Gross Profit
5.44MGBPFY2025 · Mar 31, 2025Operating Income
-395.00KGBP-533.46K · vs all stocks (USD)
Pre-tax Income
1.57MGBPFY2025 · Mar 31, 2025Income Tax Expense
0.00GBPFY2025 · Mar 31, 2025Net Income
1.57MGBPFY2025 · Mar 31, 2025EBIT
1.58MGBPFY2025 · Mar 31, 2025EBITDA (Income Statement)
367.00KGBPFY2025 · Mar 31, 2025Selling, General & Administrative
6.12MGBPFY2025 · Mar 31, 2025Non-operating Interest Income
147.00KGBPFY2025 · Mar 31, 2025Non-operating Interest Expense
17.00KGBPFY2025 · Mar 31, 2025EPS (Basic)
0.0070GBPFY2025 · Mar 31, 2025EPS (Diluted)
0.0070GBPFY2025 · Mar 31, 2025Basic Shares Outstanding
237.95MSharesFY2025 · Mar 31, 2025Diluted Shares Outstanding
237.95MSharesFY2025 · Mar 31, 2025Net Income from Continuing Operations
1.57MGBPFY2025 · Mar 31, 2025Preferred Stock Dividends
0.00GBPFY2025 · Mar 31, 2025Operating Cash Flow
-1.24MGBPFY2025 · Mar 31, 2025Free Cash Flow
-1.47MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents (End of Period)
4.87MGBPFY2025 · Mar 31, 2025Starting Profit (CF Statement)
1.57MGBPFY2025 · Mar 31, 2025Stock-based Compensation
186.00KGBPFY2025 · Mar 31, 2025Other Non-cash Items
-130.00KGBPFY2025 · Mar 31, 2025Change in Accounts Receivable (CF)
-141.00KGBPFY2025 · Mar 31, 2025Change in Other Assets/Liabilities
-2.72MGBPFY2025 · Mar 31, 2025Capital Expenditures
-225.00KGBPFY2025 · Mar 31, 2025Net Intangibles (CF)
-157.00KGBPFY2025 · Mar 31, 2025Net Investing Cash Flow
-225.00KGBPFY2025 · Mar 31, 2025Long-term Debt Payments
-140.00KGBPFY2025 · Mar 31, 2025Net Financing Cash Flow
-140.00KGBPFY2025 · Mar 31, 2025Shares Outstanding
237.95MSharesUpdated Jul 28, 2026Float Shares
187.43MSharesUpdated Jul 28, 2026% Held by Insiders
25.47%vs all stocks
% Held by Institutions
4.60%vs all stocks
Total Cash (MRQ)
3.59MGBP4.85M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0150GBPUpdated Jul 28, 2026Total Debt (MRQ)
237.00KGBP320.08K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0214xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.25xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.0460GBPUpdated Jul 28, 2026Total Assets
13.65MGBP18.43M · vs all stocks (USD)
Total Current Assets
7.66MGBPFY2025 · Mar 31, 2025Total Liabilities
2.24MGBPFY2025 · Mar 31, 2025Total Non-current Assets
5.99MGBPFY2025 · Mar 31, 2025Total Non-current Liabilities
126.00KGBPFY2025 · Mar 31, 2025Total Current Liabilities
2.12MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents
4.87MGBPFY2025 · Mar 31, 2025Accounts Receivable
1.46MGBPFY2025 · Mar 31, 2025Inventory
829.00KGBPFY2025 · Mar 31, 2025Accounts Payable
766.00KGBPFY2025 · Mar 31, 2025Short-term Debt
223.00KGBPFY2025 · Mar 31, 2025Long-term Debt
126.00KGBPFY2025 · Mar 31, 2025Common Stock (Book)
10.26MGBPFY2025 · Mar 31, 2025Retained Earnings
-23.83MGBPFY2025 · Mar 31, 2025Total Shareholders' Equity
11.41MGBP15.41M · vs all stocks (USD)
52-Week Low
1.60GBXUpdated Jul 28, 202652-Week High
3.75GBXUpdated Jul 28, 202652-Week Change
-53.33%vs all stocks
Beta
1.91xvs all stocks
50-Day MA
1.81GBXUpdated Jul 28, 2026200-Day MA
2.02GBXUpdated Jul 28, 2026Avg 10-Day Volume
119.66KSharesUpdated Jul 28, 2026Avg 30-Day Volume
128.71KSharesUpdated Jul 28, 2026Diluted EPS (TTM)
0.0100GBPUpdated Jul 28, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $5.62M, lower than 95% of all stocks globallySignificant
Market cap (USD): 5,623,791.335Global P5: 275,556,405.438
Revenue is $10.88M, lower than 95% of all stocks globallySignificant
Revenue (USD): 10,883,921.27Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Plexus Holdings plc
Tier 1ProductionThroughput-Bound ConversionRule
Airtouch Solar Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
HomeBiogas Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Foresight Autonomous Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Quantum Data Energy PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
Airea plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Clean Power Hydrogen plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Eenergy Group Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Directa Plus Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Eco Buildings Group plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationMinimal Tax and Interest Drag
Hafnia Limited
1 interpretationMinimal Tax and Interest Drag
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMinimal Tax and Interest Drag